AliveCor Logo

I nostri prodotti

Kardia 12L

Novità

KardiaMobile 6L
InstantQT
KardiaPro
Dispositivi ECG Kardia

Le nostre soluzioni

Screening della fibrillazione atriale
Soluzioni di integrazione dati
Fornitori di servizi sanitari
BioPharma

Informazioni

Leadership
Missione
Ricerca clinica
I nostri partner
Acquisti tutti i prodotti
Centro risorse
Phone
800934336
Contatti
AliveCor Logo
AliveCor Logo

Numero di supporto:

  • Danimarca: 80827060
  • Francia: 0805220703
  • Germania: 08001810996
  • Israele: 1809344393
  • Italia: 800934336
  • Regno Unito: 08000668028
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
    • Missione
    • Leadership
    • Ricerca
    • Carriere
    • Novità
    • Hub delle risorse
    • Domande frequenti
    • Manuali utente
    • Spedizione
    • Garanzia
    • Partner
    • Integrazione
  • Kardia by AliveCor
    • KardiaMobile 6L
    • KardiaMobile
    • KardiaCare
    • Internazionale
    • Piano di riduzione del carbonio
    • Dichiarazione sulla schiavitù moderna

Numero di supporto:

  • Danimarca: 80827060
  • Francia: 0805220703
  • Germania: 08001810996
  • Israele: 1809344393
  • Italia: 800934336
  • Regno Unito: 08000668028
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • Informativa sulla privacy
  • Sicurezza
  • Consenso informato sulla telemedicina
  • Termini
  • Accessibilità

©2024 AliveCor, Inc. Tutti i diritti riservati. Brevetti www.alivecor.com/patents. AliveCor e Kardia sono marchi di AliveCor, Inc. negli Stati Uniti e in altri paesi. Apple è un marchio registrato di Apple, Inc. negli Stati Uniti e in altri paesi. App Store è un marchio di servizio di Apple, Inc. Android è un marchio registrato di Google Inc. Google Play è un marchio registrato di Google Inc.

Torni indietro
U.K. Hospitals to Use New AliveCor Heart Monitor During Heart Rhythm
SAN FRANCISCO Calif., 3 giugno 2013

Week June 3-9

Availability of innovative mobile ECG monitor to aid in the screening and monitoring of heart conditions

AliveCor, Inc. announced today that more than 20 hospitals in the United Kingdom will use the AliveCor Heart Monitor during the 10th annual Heart Rhythm Awareness Week June 3–9, sponsored by Arrhythmia Alliance, The Heart Rhythm Charity in the U.K.

Heart Rhythm Week is an annual awareness week that aims to give everyone the opportunity to raise awareness and promote better understanding of heart rhythm disorders. While manual pulse checks have long been a focus of educational activity during the week, this will be the first time that hospitals/GP surgeries – from the Highlands to Jersey – will use the new ECG technology.

The AliveCor Heart Monitor is the first CE-marked mobile device-based ECG monitor that is used to record, display, store, and transfer single-channel ECG rhythms. The device snaps onto the back of an iPhone and is used with the corresponding AliveECG app. Recorded rhythm strips can be of any duration, and are stored in the app and securely in the cloud for reviewing, analysis, and printing through AliveCor’s website. Cloud storage is compliant with EU Data Privacy & Safe Harbor in the European Union. ECG data is accessible anytime, anywhere.

“Helping people understand their pulse and how it can be a warning sign for a potentially fatal heart rhythm disorder has long been a cornerstone of our educational activity and forms the basis of one of our key campaigns: Know Your Pulse .” said Trudie Lobban MBE, Founder and CEO of Arrhythmia Alliance and AF Association. “During World Heart Rhythm Week and beyond, we will be encouraging healthcare professionals and the public to realize the potential of technology such as the AliveCor ECG monitor to ‘ Know Your Pulse’ .”

Arrhythmias currently affect more than 2 million people in the U.K. with an additional 200,000 individuals diagnosed each year. The AliveCor Heart Monitor brings an easy and cost-effective way for physicians, patients and health-conscious individuals to record clinical quality, single-channel ECG rhythms. The portability and convenience of the device gives instant access when symptoms arise, potentially aiding faster management and therapy decisions to reduce the risk of stroke.

Francis White has joined the AliveCor Team as General Manager EU to manage and grow the European business. White comes with a wealth of experience in the healthcare industry. He spent the last 10 years at Medtronic, Inc. and most recently was the Business Director of Cardiac Rhythm Disease Management, U.K. & Ireland. He will be directing the expansion of AliveCor’s products and services throughout Europe in 2013 and building from the successful introduction of the Heart Monitor in the U.S. earlier this year.

“Francis brings a proven track record of success in Europe in the medical device space,” said Dan Sullivan, President & CEO at AliveCor. “Francis is a welcome addition for AliveCor as we continue to expand our services and offerings, supporting our mission of, everyone’s health at their fingertips.”

Trasformiamo insieme la cura cardiovascolare

Se lei è un datore di lavoro o un pagatore in cerca di una soluzione aziendale completa per la salute del cuore, ci contatti.